As immune checkpoint inhibitors begin to reshape how to treat patients with cancer, understanding treatment-free survival as an endpoint in clinical research can better characterize the effects of the treatment.
Meredith M. Regan, ScD
Advertisement
Articles by Meredith M. Regan, ScD
Advertisement
Latest Updated Articles
Utilizing Treatment Free Survival as an Endpoint in ResearchNovember 28th 2019
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Daraxonrasib in Pancreatic Cancer: What Oncology Nurses Need to Know
2
Managing Erectile Dysfunction in Prostate Cancer
3
Real-World Liso-cel Safety: Key Nursing Insights for R/R MCL Management
4
Fox Chase Study: Improving Retention for Early-Career Oncology Nurses
5